No analyst coverage available for this stock.
ARK Genomic Revolution ETF is an actively managed exchange-traded fund focused on companies tied to the genomics revolution. ARK Genomic Revolution ETF seeks exposure to businesses involved in areas such as DNA sequencing, gene editing, CRISPR-based tools, molecular diagnostics, bioinformatics, and precision therapeutics. The portfolio is designed to capture companies that develop, enable, or benefit from scientific advances in genomic healthcare and related life sciences. Its holdings typically span healthcare and adjacent innovation-driven sectors, with an emphasis on firms offering products and services used in research, clinical testing, and next-generation medical applications. As a thematic equity ETF, ARK Genomic Revolution ETF serves as a concentrated vehicle for investors looking to access a specialized segment of the healthcare and biotechnology market through a single fund.